Skip to main content

Kansas To Get $6M From Mallinckrodt Over Opioid Crisis

Kansas To Get $6M From Mallinckrodt Over Opioid Crisis

Kansas To Get $6M From Mallinckrodt Over Opioid Crisis

Introduction

Mallinckrodt Pharmaceuticals plc will pay at least $6 million to Kansas as per Kansas' Attorney General's order over the company's role in the national opioid crisis.

The approval of the fund distribution was part of Mallinckrodt’s bankruptcy proceedings. Kansas would use the funds to address substance abuse and addiction. The AG's office of Kansas has now recovered nearly $200 million over the lawsuits related to illegal opioid manufacturing, marketing and distribution.

The AG said that he has worked hard to reach the settlement and make the drug manufacturing companies pay for their unlawful business practices, which led to addiction and human suffering. Kansas will receive the payment over the next eight years.

Earlier in February, the AG finalized and approved a $26 billion opioid settlement involving the nation’s three major pharmaceutical distributors and manufacturer Johnson & Johnson. It would clear the way for the states' and local governments' funds to treat and prevent opioid addiction.

Johnson & Johnson and the distributors would pay $35 million and $153 million, respectively, to Kansas and its local government. The AG even reached a settlement with McKinsey & Company in 2021 over its roles in the opioid epidemic, where the firm would pay $4.8 million to Kansas for drug treatment and addiction abatement.

The settlement would be distributed under the Kansas Fights Addiction Act, which focuses on addressing substance abuse and helping ensure addiction services are provided throughout the state. A grant review board has been created by the statute to execute the funding process of addiction treatment and abatement.

The AG's office has recovered more than $1 billion for Kansas consumers and taxpayers since 2011, which is far better than the previous administration.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!